Corvus Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Corvus Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2016 to Q3 2024.
  • Corvus Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 194 %, a 55.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 194 -246 -55.9% Sep 30, 2024
Q2 2024 386 -25.8 -6.26% Jun 30, 2024
Q1 2024 424 -14.9 -3.39% Mar 31, 2024
Q4 2023 444 -50.5 -10.2% Dec 31, 2023
Q3 2023 439 -131 -23% Sep 30, 2023
Q2 2023 412 -264 -39.1% Jun 30, 2023
Q1 2023 439 -227 -34.1% Mar 31, 2023
Q4 2022 494 -115 -18.9% Dec 31, 2022
Q3 2022 571 +43.6 +8.28% Sep 30, 2022
Q2 2022 676 +209 +44.6% Jun 30, 2022
Q1 2022 665 +207 +45.3% Mar 31, 2022
Q4 2021 609 +128 +26.6% Dec 31, 2021
Q3 2021 527 -49.6 -8.61% Sep 30, 2021
Q2 2021 468 -224 -32.4% Jun 30, 2021
Q1 2021 458 -337 -42.4% Mar 31, 2021
Q4 2020 481 -471 -49.5% Dec 31, 2020
Q3 2020 577 -562 -49.4% Sep 30, 2020
Q2 2020 692 -613 -47% Jun 30, 2020
Q1 2020 795 -656 -45.2% Mar 31, 2020
Q4 2019 953 -526 -35.6% Dec 31, 2019
Q3 2019 1.14K -197 -14.7% Sep 30, 2019
Q2 2019 1.31K +106 +8.83% Jun 30, 2019
Q1 2019 1.45K +302 +26.3% Mar 31, 2019
Q4 2018 1.48K +294 +24.8% Dec 31, 2018
Q3 2018 1.34K -93.4 -6.54% Sep 30, 2018
Q2 2018 1.2K -605 -33.5% Jun 30, 2018
Q1 2018 1.15K -1.31K -53.3% Mar 31, 2018
Q4 2017 1.18K -2K -62.8% Dec 31, 2017
Q3 2017 1.43K -2.08K -59.3% Sep 30, 2017
Q2 2017 1.8K Jun 30, 2017
Q1 2017 2.46K Mar 31, 2017
Q4 2016 3.18K Dec 31, 2016
Q3 2016 3.51K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.